Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

With the threat of Trump administration's tariffs swirling and biopharma companies bracing for impact, many are announcing ...

Thermo Fisher Scientific shares jumped Thursday after the medical device maker reported better-than-expected fourth-quarter results. Sales and profit increased year-over-year and topped Visible ...

The science-services and instruments provider is expanding operations in the U.S. as companies rearrange manufacturing to avoid new global tariffs. The pharmaceutical industry has long been exempt ...

Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit ...

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the ... and state-of-the art imaging device into a single bench-top instrument.

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter ...

Dr. Nimesh Khadka discusses Raman spectroscopy's role in bioprocess monitoring, highlighting its advantages in molecular ...

He painted a similar picture for medical device stocks that are more US-centric ... by 150 percentage points (see more details here). Thermo Fisher Scientific Inc. (NYSE:TMO) provides analytical ...

In February the company had announced its plan to separate the unit, which consists of biosciences and diagnostic solutions, after the Financial Times reported that activist Starboard Value had taken ...

Thermo Fisher has outlaid $2bn to expand manufacturing and development in the US, joining the long list of companies directing resources to domestic operations as ongoing US tariffs risk ...